1.94
price down icon1.52%   -0.03
after-market Handel nachbörslich: 1.94
loading

Immutep Limited Adr Aktie (IMMP) Neueste Nachrichten

pulisher
May 08, 2025

Market Highlights: Immutep Limited ADR (IMMP) Ends on a Low Note at 1.93 - DWinneX

May 08, 2025
pulisher
May 05, 2025

Immutep stock soars on promising trial results By Investing.com - Investing.com Nigeria

May 05, 2025
pulisher
May 05, 2025

Immutep stock soars on promising trial results - Investing.com Australia

May 05, 2025
pulisher
Apr 29, 2025

Immutep Quarterly Activities Report Q3 FY25 - The Manila Times

Apr 29, 2025
pulisher
Apr 02, 2025

Immutep to Participate in Upcoming Investor Conferences - GlobeNewswire Inc.

Apr 02, 2025
pulisher
Mar 24, 2025

Immutep Limited (ASX:IMM) Initiates Phase III Trial for Non-Small Cell Lung Cancer - thecapitalclub.com.au

Mar 24, 2025
pulisher
Feb 11, 2025

Is Immutep Limited (IMMP) the Best Long Term ASX Stock to Buy Now? - AInvest

Feb 11, 2025
pulisher
Jan 14, 2025

Immutep Limited (NASDAQ:IMMP) Shares Sold by Jane Street Group LLC - Defense World

Jan 14, 2025
pulisher
Dec 18, 2024

Verition Fund Management LLC Has $57,000 Stock Position in Immutep Limited (NASDAQ:IMMP) - Defense World

Dec 18, 2024
pulisher
Dec 17, 2024

Immutep Announces Initial Safety Data from First-in-Human Phase I Trial Evaluating IMP761 - The Manila Times

Dec 17, 2024
pulisher
Dec 12, 2024

Immutep shares new cancer study results - Investing.com

Dec 12, 2024
pulisher
Oct 29, 2024

Immutep Quarterly Activities Report Q1 FY25 - Yahoo Finance

Oct 29, 2024
pulisher
Oct 17, 2024

Immutep Announces First-in-Human Phase I Study of IMP761 Progresses to Dose Escalation Portion of Trial - Yahoo Finance

Oct 17, 2024
pulisher
Jul 22, 2024

Immutep Announces Successful Meeting with FDA on Phase III Design in Non-Small Cell Lung Cancer - GlobeNewswire

Jul 22, 2024
pulisher
Jun 27, 2024

Baird cuts Immutep stock target on phase 2b trial results, retains Outperform - Investing.com

Jun 27, 2024
pulisher
Apr 18, 2024

Immutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP761 - GlobeNewswire

Apr 18, 2024
pulisher
Feb 05, 2024

10 Best Australian Stocks To Buy - Yahoo Finance

Feb 05, 2024
pulisher
Mar 30, 2023

Immutep Announces Expansion of Triple Combination Therapy in 1st Line Non-Small Cell Lung Cancer - GlobeNewswire

Mar 30, 2023
pulisher
Nov 03, 2022

Check Up: These 4 ASX healthcare stocks come with Strong Buy recommendations - Stockhead

Nov 03, 2022
pulisher
Dec 16, 2021

ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire

Dec 16, 2021
pulisher
Apr 08, 2021

FDA Grants Fast Track Designation to 1L Eftilagimod Alpha for Recurrent or Metastatic HNSCC - Targeted Oncology

Apr 08, 2021
pulisher
Dec 30, 2020

Best Penny Stocks To Buy For 2021? 5 Biotech Stocks To Watch - Penny Stocks

Dec 30, 2020
pulisher
Sep 06, 2020

IMMPImmutep Latest Stock News & Market Updates - Stock Titan

Sep 06, 2020
pulisher
Jul 15, 2020

The Daily Biotech Pulse: Moderna To Kickstart Phase 3 Study On July 27, Immutep Awarded Antibody Patent - Yahoo Finance

Jul 15, 2020
pulisher
Apr 18, 2019

Immutep Ltd (IMMP) Stock Price, Trades & News - GuruFocus

Apr 18, 2019
pulisher
Dec 10, 2017

A Full List of Australia ADRs - Investing.com Australia

Dec 10, 2017
pulisher
Dec 05, 2017

Immutep (IMMP) Stock Price, News & Analysis - MarketBeat

Dec 05, 2017
pulisher
May 14, 2017

Prima BioMed Share Price | NASDAQ IMMP Stock - Investing.com Australia

May 14, 2017
pulisher
May 13, 2017

Prima BioMed Stock Price Today | NASDAQ: IMMP Live - Investing.com

May 13, 2017
pulisher
May 13, 2017

Prima BioMed Stock Price Today | NASDAQ IMMP - Investing.com Canada

May 13, 2017
pulisher
Jul 27, 2011

ADVFN | Live Stock, Options & Crypto Market Data, Trading Tools & Community - advfn.com

Jul 27, 2011
$1.15
price down icon 17.27%
$31.32
price down icon 3.63%
$587.61
price up icon 1.06%
$289.96
price up icon 0.33%
$4.25
price up icon 0.48%
$75.06
price up icon 3.26%
Kapitalisierung:     |  Volumen (24h):